Pair Name | Curcumol, Doxorubicin | ||
Phytochemical Name | Curcumol (PubChem CID: 14240392 ) | ||
Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Curcumol, Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | ABCC3 | hsa8714 |
Up-regulation | Expression | MIR181B2 | KEGG ID N.A. | |
Up-regulation | Activity | NFATC2 | hsa4773 | |
In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
In Vivo Model | MDA-MB-231-luc cells were suspended in a 1:1 mixture of saline/Matrigel and injected into the mammary fat pads of six-week-old female nude mice (n = 5 animals; 100 μL and 5×10⁶ cells per animal). | |||
Result | Our study provides novel mechanistic evidence for curcumol-mediated sensitization to doxorubicin in TNBC, and it highlights the potential therapeutic usefulness of curcumol as an adjunct drug in TNBC patients with doxorubicin-resistance. |
No. | Title | Href |
---|---|---|
1 | Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis. Biochem Pharmacol. 2020 Apr;174:113795. doi: 10.1016/j.bcp.2020.113795. | Click |